Gene: EPHB1
Official Full Name: EPH receptor B1provided by HGNC
Gene Summary: Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene is a receptor for ephrin-B family members. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38015 | EPHB1 Knockout cell line (HEK293) | Human | EPHB1 | 1:3~1:6 | Negative | Online Inquiry |
EPHB1 Gene Knockout Cell Lines are specialized cellular models that have undergone targeted gene inactivation of the EPHB1 gene, which encodes for Ephrin type-B receptor 1. This receptor is pivotal in cell signaling mechanisms that regulate various biological processes, including cellular adhesion, migration, and axon guidance. By creating knockout models, researchers are provided with a powerful tool to elucidate the distinct roles of EPHB1 in development and disease.
The primary function of these knockout cell lines lies in their ability to mimic pathological conditions where EPHB1 signaling is disrupted. This facilitates detailed investigations into its influence on cellular behavior, including proliferation and apoptosis. One mechanism through which the EPHB1 receptor exerts its effects is the modulation of Rho GTPases, which are crucial for cytoskeletal organization. The knockout models enable scientists to dissect these pathways more precisely by comparing them to wild-type counterparts.
In terms of scientific importance, EPHB1 has been implicated in several diseases, including cancer and neurological disorders, making these cell lines invaluable for translational research. They allow for assessments of therapeutic interventions aimed at modulating EPHB1 signaling, an area of great interest in developing innovative treatment strategies.
What sets our EPHB1 Gene Knockout Cell Lines apart from alternatives is their exceptional reliability and reproducibility. Manufactured under stringent quality control conditions, these cell lines are confirmed by genomic sequencing, ensuring that researchers receive a product with guaranteed efficacy. This distinction enhances experimental design, reduces variability, and can lead to more reliable results.
Researchers and clinicians alike will find these knockout cell lines to be an essential addition to their laboratories, providing insights that are critical for understanding the role of EPHB1 in health and disease. Our commitment to excellence in biological products is reflected in our rigorous development processes and analytical validation methods, ensuring that our offerings meet the highest scientific standards.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.